Why I’d ditch this falling knife to buy Royal Dutch Shell plc

Royal Dutch Shell plc (LON:RDSB) could climb further than you expect, says Roland Head.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

When do you sell a losing position? Shareholders of food production biotech group Benchmark Holdings (LSE: BMK) were probably asking that question on Friday morning, when management backtracked on previous guidance and triggered a 14% share price fall.

The company’s shares have now fallen by 47% this year. Should shareholders simply ditch this disappointing stock before things get worse?

What’s gone wrong?

One of the firm’s big hopes is a new treatment for sea lice, which have become a serious problem for producers of farmed salmon. Back in June, the company said commercial trials were due to start “in the coming weeks”. The product was expected to contribute “significant revenues” in the second half of the year.

Unfortunately, this hasn’t happened. In Friday’s update, we learned that the trials have still not started and are unlikely to do so before the end of September when the company’s financial year ends. This means the new product won’t make any contribution to revenue in the 2017 financial year.

This is disappointing as revenue from the new product was expected to offset falling sales of Benchmark’s older sea lice treatment Salmosan. This decline is serious. Sales in the group’s Animal Health division fell from £12.2m to £7.1m during the first half of this year. The division’s operating loss doubled from £3.2m to £6.7m during the same period.

Full-year outlook

Profit forecasts for 2017 were slashed in November last year, after the group warned of delayed investment and lower growth rates in certain sectors. Friday’s news is another disappointment.

Benchmark reported a pre-tax loss of £22.4m last year. Analysts expected the group to report adjusted earnings of 0.68p per share this year. But even if these forecasts are left unchanged, the stock still trades on a forecast P/E of 66. There are big hopes for 2018, but I don’t think the shares are cheap enough to be worth the risk.

I’d buy this instead

Benchmark’s management has promised more than they can deliver. By contrast, Royal Dutch Shell (LSE: RDSB) chief executive Ben van Beurden has delivered exactly what he promised.

Mr van Beurden has reduced the group’s net debt, improved cash flow and made good progress with planned asset sales. At about £22, Shell’s share price has risen off the lows of £14 seen at the start of 2016. But I think the stock still offers a useful amount of upside

The acquisition of BG Group is starting to look like a smart move, and the stock still offers a dividend yield of around 6.4%. This payout should be covered by earnings this year. In my opinion, this pretty much eliminates any risk of a dividend cut.

What about upside?

All of that is fair enough, but with Shell trading on a forecast P/E of 14.8, surely potential gains are limited? I’m not so sure. I believe the final stage of the oil and gas group’s recovery will come when the price of oil rises to a more sustainable level.

The extensive cost-cutting that’s taken place across the industry means that a fairly small increase in the price of oil could drive a big increase in profits. I believe this is inevitable at some point in the next year or two. In the meantime, this 6%+ dividend yield continues to reward patient shareholders.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Roland Head has no position in any of the shares mentioned. The Motley Fool UK has recommended Royal Dutch Shell B. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Passive income text with pin graph chart on business table
Investing Articles

Yields of up to 7%! I’d consider boosting my income with these FTSE dividend stocks

The London market has some decent-looking dividend stocks right now, and I’m tempted by these two for growing income streams.

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

I’d put £20K in an ISA now to target a £1,900 monthly second income in future!

Christopher Ruane shares why he thinks a long-term approach to investing and careful selection of shares could help him build…

Read more »

Mature couple at the beach
Investing Articles

6 stocks that Fools have been buying!

Our Foolish freelancers are putting their money where their mouths are and buying these stocks in recent weeks.

Read more »

Black woman using loudspeaker to be heard
Investing Articles

I was right about the Barclays share price! Here’s what I think happens next

Jon Smith explains why he still feels the Barclays share price is undervalued and flags up why updates on its…

Read more »

Investing Articles

Where I’d start investing £8,000 in April 2024

Writer Ben McPoland highlights two areas of the stock market that he would target if he were to start investing…

Read more »

View of Tower Bridge in Autumn
Investing Articles

Ahead of the ISA deadline, here are 3 FTSE 100 stocks I’d consider

Jon Smith notes down some FTSE 100 stocks in sectors ranging from property to retail that he thinks could offer…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

Why I think Rolls-Royce shares will pay a dividend in 2024

Stephen Wright thinks Rolls-Royce shares are about to pay a dividend again. But he isn’t convinced this is something investors…

Read more »

Investing Articles

1 of the best UK shares to consider buying in April

Higher gold prices and a falling share price have put this FTSE 250 stock on Stephen Wright's list of UK…

Read more »